Obesity and Diabetes Therapy
Studies from Kyung-Hee University, Medical Research Center for Bioreaction to Reactive Oxygen Species reveal new findings on obesity and diabetes therapy
Published in Obesity and Diabetes Week, July 30th, 2007
A new study, "Antidiabetes and antiobesity effect of cryptotanshinone via activation of AMP-activated protein kinase," is now available. According to a study from Seoul, Korea, "Metabolic disorders, including type 2 diabetes and obesity, represent major health risks in industrialized countries. AMP-activated protein kinase (AMPK) has become the focus of a great deal of attention as a novel therapeutic target for the treatment of metabolic syndromes, because AMPK has been demonstrated to mediate, at least in part, the effects of a number of physiological and pharmacological factors that exert beneficial effects on these disorders."
"Thus, the identification of a compound...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Centre for Evidence Based Paediatrics Gastroenterology and Nutrition
Lentils better than white bread for dieting - Obesity
Aggressive efforts needed to curb maternal obesity - Obesity
Can P.E. Class Really Make a Difference in Children’s Fitness? - Obesity
Eating Nutritional Foods Can Help Children Be at Their Best Academically - Obesity
Pediatricians say advice to obese kids and families falls on deaf ears - Obesity and Diabetes
Overweight Children: An Emerging Epidemic - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
